Recro Pharma Stock Price (NASDAQ:REPH)

Add to My Stocks
$7.96 $0.03 (0.38%) REPH stock closing price Mar 24, 2017 (Closing)
Prev Close* : $7.93
Market Cap:
$151.07M
Day Low: $7.87
52 Week Low: $5.74
Open: $7.92
Volume: 176552
Day High: $8.12
52 Week High: $12.50
Dividend:
N/A

Latest Stock Market News

Latest Articles

Recro Pharma News - From Partners

REPH Stockcharts

View REPH PE ratio, PS ratio stocks charts and compare with peers.
REPH Chart
Note: Compare Recro Pharma stock price history with the index and industry peers.

Recro Pharma Valuation

PS ratio (
price to sales ratio
)
1.23
PB ratio (
price to book ratio
)
1.95

Recro Pharma Financial Ratios

Asset Turnover
0.49
Receivables Turnover
6.32
Debt to Equity
0.6

REPH Industry Peers

Company Price Change (%)
Merus Labs International (MSLI)0.860.03 (3.37%)
Medicure (MCUJF)7.090.16 (2.31%)
Catalent (CTLT)28.030.06 (0.21%)
Elite Pharma (ELTP)0.150 (0%)
Zogenix (ZGNX)10.450.05 (0.48%)
Trevena (TRVN)3.550.04 (1.11%)
Pernix Therapeutics (PTX)3.970.08 (2.06%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)7.40.32 (4.52%)
Tesaro Inc (TSRO)1606.38 (4.15%)
Ignyta (RXDX)9.250.35 (3.93%)
Flexion Therapeutics (FLXN)27.271.02 (3.89%)
BioCryst Pharma (BCRX)8.7850.3 (3.53%)
Xencor (XNCR)24.530.82 (3.46%)
Infinity Pharma (INFI)3.30.1 (3.13%)
Top gainers from Medical-Drugs industry
* As of Mar 25, 2017
CompanyPriceChange (%)
MediWound (MDWD)6.40.27 (4.04%)
Nature's Sunshine Products (NATR)9.150.35 (3.68%)
Esperion Therapeutics (ESPR)38.941.46 (3.61%)
Merus Labs International (MSLI)0.860.03 (3.37%)
Concert Pharma (CNCE)17.3950.48 (2.68%)
GlycoMimetics (GLYC)5.560.12 (2.11%)
Aralez Pharma (ARLZ)2.190.04 (1.79%)
Top losers from Medical-Drugs industry
* As of Mar 25, 2017

Recro Pharma Inc Stock News - Partner Headlines

Recro Pharma Financial Statements

income statement201520142013
Net Sales Or Revenues51.95M--
Net Income3.03M-16.13M-1.95M
Total Operating Expense30.86M11.86M1.08M
view Recro Pharma Inc income statement
balance sheet201520142013
Total Assets138.69M20.37M0.85M
Total Liabilities98.34M1.44M12.93M
Shareholders Equity40.35M18.92M-12.07M
view Recro Pharma Inc balance sheet
cash flow statement201520142013
Net Increase (Decrease) In Assets Liabilities7.64M0.46M0.27M
Net Cash From (Used By) Operating Activities8.45M-10.86M-0.81M
Increase (Decrease) In Prop Plant And Equipment-2.41M--
view Recro Pharma Inc cashflow statement

Recro Pharma Stock Message Board

An investor needs to spend 7.96 to buy REPH stock, as the closing Recro Pharma stock price is 7.96. Stock price or share price can be used to find the total market value of a company. Recro Pharma market cap stands at 151.07M as of 24 Mar, 2017. Recro Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy REPH stock than sell it, then Recro Pharma stock price goes up. Conversely, if more investors wanted to sell REPH stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Recro Pharma stock quote data shows the number of shares traded. For Ex: 176552 Recro Pharma shares were traded as of last trading day, as seen from Recro Pharma stock chart. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Recro Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of REPH, view Recro Pharma stock price history.